Oxidative stress parameters in paediatric non-alcoholic fatty liver disease

International Journal of Molecular Medicine

Volumn 26, Issue 4, 2010, Pages 471-476

  Nobili, Valerio ^a   Parola, Maurizio ^d   Alisi, Anna ^a   Marra, Fabio ^b   Piemonte, Fiorella ^a   Mombello, Cristina ^c   Sutti, Salvatore ^c   Povero, Davide ^d   Maina, Virginia ^c   Novo, Erica ^d   Albano, Emanuele ^c  

^a BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^d UNIVERSITY OF TURIN   (Italy)

Author keywords

Non alcoholic fatty liver disease; Non alcoholic fatty liver disease activity score; Non alcoholic steatohepatitis; Oxidative stress

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; CARBONYL DERIVATIVE; HUMAN SERUM ALBUMIN; IMMUNOGLOBULIN G ANTIBODY; MALONALDEHYDE;

ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN TISSUE; INSULIN RESISTANCE; LIVER BIOPSY; LIVER CELL; LIVER FIBROSIS; MALE; NONALCOHOLIC FATTY LIVER; OBESITY; OBSERVATIONAL STUDY; OXIDATIVE STRESS; PREVALENCE; PRIORITY JOURNAL; SCORING SYSTEM;

BLOOD PROTEINS; CHILD; DEOXYGUANOSINE; FATTY LIVER; FEMALE; HUMANS; IMMUNOGLOBULIN G; LIPID PEROXIDATION; LIVER; MALE; MALONDIALDEHYDE; OXIDATIVE STRESS; SERUM ALBUMIN;

EID: 77957863577     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm_00000487     Document Type: Article

References (41)

1. Reilly JJ: Obesity in childhood and adolescence: evidence-based clinical and public health perspectives. Postgrad Med J 82: 429-437, 2006.
2. Roberts E: Pediatric non-alcoholic fatty liver disease (NAFLD): a 'growing' problem? J Hepatol 46: 1133-1142, 2007.
3. Manco M, Bottazzo G, DeVito R, Marcellini M, Mingrone G and Nobili V: Nonalcoholic fatty liver disease in children. J Am Coll Nutr 27: 667-676, 2008.
4. Adams LA, Lymp JF, St. Sauver J, et al: The natural history of non-alcoholic fatty liver disease: a population-based cohort study. Gastroenterology 129: 113-121, 2005.
5. Nobili V, Marcellini M, Devito R, Ciampalini P, Piemonte F and Comparcola D: NAFLD in children: a prospective clinical-pathological study and effect of lifestyle advice. Hepatology 44: 458-465, 2006.
6. Adams LA, Sanderson S, Lindor KD and Angulo P: The histological course of non-alcoholic fatty liver disease: a longitudinally study of 103 patients with sequential liver biopsies. J Hepatol 42: 132-138, 2005.
7. Cortez-Pinto H, Caneiro de Moura M and Day CP: Non-alcoholic steatohepatitis: from cell biology to clinical practice. J Hepatol 44: 197-208, 2006.
8. Marra F, Gastaldelli A, Svegliati Baroni G, Tell G and Tiribelli C: Molecular basis and mechanisms of progression of non-alcoholic steatohepatitis. Trends Mol Med 14: 72-81, 2008.
9. Laurent A, Nicco C, Tran Van Nhieu J, et al: Pivotal role of superoxide anion and benefical effect of antioxidant molecules in murine steatohepatitis. Hepatology 39: 1277-1285, 2004.
10. Ronis MJ, Butura A, Korourian S, et al: Cytokine and chemokine expression associated with steatohepatitis and hepatocyte proliferation in rats fed ethanol via total enteral nutrition. Exp Biol Med 233: 344-355, 2008.
11. Seki S, Kitada T, Yamada T, Sakaguchi H, Nakatani K and Wakasa K: In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver disease. J Hepatology 37: 56-62, 2002
12. Chalasani N, Deeg MA and Crabb DW: Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with non-alcoholic steatohepatitis. Am J Gastroenterol 99: 1497-1502, 2004.
13. Ikura Y, Ohsawa M, Suekane T, et al: Localization of oxidized phosphatidylcholine in non-alcoholic fatty liver disease; impact on disease progression. Hepatology 43: 506-514, 2006.
14. Sreekumar R, Rosado B, Rasmussen D and Charlton M: Hepatic gene expression in histologically progressive nonalcoholic steatohepatitis. Hepatology 38: 244-251, 2003.
15. Nobili V, Manco M, Devito R, Ciampalini P, Piemonte F and Marcellini M: Effect of vitamin E on aminotransferase levels and insulin resistance in children with non-alcoholic fatty liver disease. Aliment Pharmacol Ther 24: 1553-1561, 2006.
16. Nobili V, Manco M, Devito R, et al: Lifestyle intervention and antioxidant therapy in children with nonalcoholic fatty liver disease: a randomized, controlled trial. Hepatology 48: 119-128, 2008.
17. Manco M and Nobili V: Intensive treatment and dietary fats in adolescents with nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr 46: 224-230, 2008.
18. Manco M, Bedogni G, Marcellini M, et al: Waist circumference correlates with liver fibrosis in children with non-alcoholic steatohepatitis. Gut 57: 1283-1287, 2008.
19. Cole TJ, Bellizzi MC, Flegal KM and Dietz WH: Establishing a standard definition for child overweight and obesity worldwide: international survey. Br Med J 320: 1240-1243, 2000.
20. Genuth S, Alberti KG, Bennett P, et al: Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 26: 3160-3167, 2003.
21. Genuth S: Lowering the criterion for impaired fasting glucose is in order. Diabetes Care 26: 3331-3332, 2003.
22. Matsuda M and DeFronzo RA: Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22: 1462-1470, 1999.
23. Abdul-Ghani MA, Matsuda M, Balas B and DeFronzo RA: Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test. Diabetes Care 30: 89-94, 2007.
24. Poynard T, Halfon P, Castera L, et al: FibroPaca Group: Variability of the area under the receiver operating characteristic curves in the diagnostic evaluation of liver fibrosis markers: impact of biopsy length and fragmentation. Aliment Pharmacol Ther 25: 733-739, 2007.
25. Kleiner DE, Brunt EM, Van Natta M, et al: Nonalcoholic Steatohepatitis Clinical Research Network. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 41: 1313-1321, 2005.
26. Novo E, Marra F, Zamara E, et al: Overexpression of Bcl-2 by activated human hepatic stellate cells: resistance to apoptosis as a mechanism of progressive hepatic fibrogenesis. Gut 55: 1174-1182, 2006.
27. Vidali M, Hietala J, Occhino G, et al: Immune responses against oxidative stress-derived antigens are associated with increased circulating tumor necrosis factor-α and accelerated liver damage in heavy drinkers. Free Rad Biol Med 45: 306-311, 2008.
28. Albano E, Mottaran E, Vidali M, et al: Immune response towards lipid peroxidation products as a predictor of progression of non-alcoholic fatty liver disease to advanced fibrosis. Gut 54: 987-993, 2005.
29. Hawkins CL, Morgan PE and Davies MJ: Quantification of protein modification by oxidants. Free Rad Biol Med 46: 965-988, 2009.
30. Molnar D, Decsi T and Koletzko B: Reduced antioxidant status in obese children with metabolic syndrome. Int J Obes Relat Metab Disord 28: 1197-1202, 2004.
31. Mohn A, Catino M, Capanna R, Giannini C, Marcovecchio M and Chiarelli F: Increased oxidative stress in prepuberal severely obese children: effect of dietary restriction-weight loss program. J Clin Endocrinol Metab 90: 2653-2658, 2005.
32. Nobili V, Pastrore A, Gaeta LM, et al: Glutathione metabolism and antioxidant enzymes in patients affected by non-alcoholic steatohepatitis. Clin Chim Acta 355: 105-111, 2005.
33. Mottaran E, Stewart SF, Rolla R, et al: Lipid peroxidation contributes to immune reactions associated with alcoholic liver disease. Free Rad Biol Med 32: 38-45, 2002.
34. Vidali M, Tripodi MF, Ivaldi A, et al: Interplay between oxidative stress and steatosis in the progression of Hepatitis C. J Hepatol 48: 399-406, 2008.
35. Albano E: Alcohol, oxidative stress and free radical damage. Proc Nutr Soc 65: 278-290, 2006.
36. Choi J and Ou JHJ: Mechanisms of liver injury III. Oxidative stress in the pathogenesis of hepatitis C virus. Am J Physiol 290: G847-G851, 2006.
37. Stewart SF, Vidali M, Day CP, Albano E and Jones DE: Oxidative stress as a trigger for cellular immune response in patients with alcoholic liver disease. Hepatology 39: 197-203, 2004.
38. Vidali M, Stewart SF and Albano E: Interplay between oxidative stress and immunity in the progression of alcohol-mediated liver injury. Trends Mol Med 14: 63-71, 2008.
39. Chou MY, Hartvigsen K, Hansen LF, et al: Oxidation-specific epitopes are important targets of innate immunity. J Intern Med 263: 479-488, 2008.
40. Ma X, Hua J, Mohamood AR, Hamad AR, Ravi R and Li Z: A high-fat diet and regulatory T cells influence susceptibility to endotoxin-induced liver injury. Hepatology 46: 1519-1529, 2007.
41. George J: Mechanisms of disease: the evolving role of regulatory T cells in atherosclerosis. Nat Clin Pract Cardiovascular Med 5: 531-540, 2008.